Ignite Creation Date:
2025-12-24 @ 11:58 PM
Ignite Modification Date:
2025-12-25 @ 9:56 PM
Study NCT ID:
NCT00437658
Status:
COMPLETED
Last Update Posted:
2018-10-12
First Post:
2007-02-16
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Elagolix Versus Subcutaneous Depot Medroxyprogesterone Acetate for the Treatment of Endometriosis
Sponsor:
AbbVie
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-12-11
Start Date Type:
ACTUAL
Primary Completion Date:
2008-11-24
Primary Completion Date Type:
ACTUAL
Completion Date:
2008-11-24
Completion Date Type:
ACTUAL
First Submit Date:
2007-02-16
First Submit QC Date:
None
Study First Post Date:
2007-02-21
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-08-09
Results First Submit QC Date:
None
Results First Post Date:
2018-10-12
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2012-02-28
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2018-09-14
Last Update Post Date:
2018-10-12
Last Update Post Date Type:
ACTUAL